JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 28, 2005
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
280/4/3012    most recent
M411522200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C. F.
Right arrow Articles by Lohnes, D. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C. F.
Right arrow Articles by Lohnes, D. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 4, 2004
J. Biol. Chem, 10.1074/jbc.M411522200
Submitted on October 8, 2004
Revised on November 4, 2004
Accepted on November 4, 2004

Dominant negative RARs elicit epidermal defects through a non-canonical pathway

C. F. Chen and David L. Lohnes

Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON K1H 8M5

Corresponding Author: dlohnes{at}uottawa.ca

Previous work has shown that a dominant-negative RARalpha (dnRARalpha ), expressed under the K14 promoter, causes severe epidermal defects. Similar defects are, however, not seen in RARalpha gamma double null mutant mice, which lack the entire complement of RARs expressed in the epidermis. To investigate the mechanism of action of such dominant-negative receptors, dnRARalpha or a DNA-binding deficient variant, dnRARalpha DBD, were targeted to the basal epidermis. Expression of either receptor type led to similar epidermal phenotypes suggesting that both RAR mutants acted through a common mechanism. The epidermal phenotype was reminiscent of defects seen in p63-/- mice. Consistent with this, reduced p63 expression was observed in transgenic offspring expressing either RAR mutant, suggesting that downregulation of p63 might underlie the effects of these receptors on epidermal development. By contrast, expression of p63 in the epidermis of RARalpha gamma -/- offspring was unaffected, indicating that RARs were not essential for p63 expression. These findings suggest that dnRARs may impact on epidermal development through a non-canonical pathway(s) which is independent of receptor-DNA interaction.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Stem CellsHome page
C. M. Metallo, L. Ji, J. J. de Pablo, and S. P. Palecek
Retinoic Acid and Bone Morphogenetic Protein Signaling Synergize to Efficiently Direct Epithelial Differentiation of Human Embryonic Stem Cells
Stem Cells, February 1, 2008; 26(2): 372 - 380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.